BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced multi-functional targeted formulation features transactivator of transcription peptide functionalized liposomes co-loaded with paclitaxel and tamoxifen. The structural matrix co-incorporates the highly hydrophobic diterpenoid paclitaxel and the triphenylethylene derivative tamoxifen directly within the lipophilic hydrocarbon tail domains of its bilayer shell, whose exterior boundary is surface-modified with transactivator of transcription (TAT) cell-penetrating peptides linked via polymer anchors. This complex layout coordinates a highly uniform charged cell-penetrating peptide layer with an optimized dual-phase hydrophobic core, completely preventing physical vesicle aggregation while completely suppressing paclitaxel or tamoxifen crystallization in open laboratory testing media.
Source
Custom synthesis
Functional Group
TAT peptide; Paclitaxel; Tamoxifen
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.